FDA Draft Guidance Clarifies Rules Of Summary Reporting Program
The program allows manufacturers of most lower-risk devices to submit reports of known adverse events via quarterly summaries, rather than individually.
The program allows manufacturers of most lower-risk devices to submit reports of known adverse events via quarterly summaries, rather than individually.